- Home
- PRME vs GLO Comparison
PRME vs GLO Comparison
Compare PRME & GLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRME
- GLO
- Stock Information
- Founded
- PRME 2019
- GLO 2006
- Country
- PRME United States
- GLO United States
- Employees
- PRME N/A
- GLO N/A
- Industry
- PRME Medicinal Chemicals and Botanical Products
- GLO Finance/Investors Services
- Sector
- PRME Health Care
- GLO Finance
- Exchange
- PRME Nasdaq
- GLO Nasdaq
- Market Cap
- PRME 191.7M
- GLO 193.7M
- IPO Year
- PRME 2022
- GLO N/A
- Fundamental
- Price
- PRME $2.71
- GLO $5.45
- Analyst Decision
- PRME Buy
- GLO
- Analyst Count
- PRME 6
- GLO 0
- Target Price
- PRME $9.38
- GLO N/A
- AVG Volume (30 Days)
- PRME 3.3M
- GLO 170.5K
- Earning Date
- PRME 08-04-2025
- GLO 01-01-0001
- Dividend Yield
- PRME N/A
- GLO 11.38%
- EPS Growth
- PRME N/A
- GLO N/A
- EPS
- PRME N/A
- GLO N/A
- Revenue
- PRME $3,846,000.00
- GLO N/A
- Revenue This Year
- PRME $104.12
- GLO N/A
- Revenue Next Year
- PRME $196.78
- GLO N/A
- P/E Ratio
- PRME N/A
- GLO N/A
- Revenue Growth
- PRME 550.76
- GLO N/A
- 52 Week Low
- PRME $1.11
- GLO $4.08
- 52 Week High
- PRME $6.75
- GLO $5.18
- Technical
- Relative Strength Index (RSI)
- PRME 69.76
- GLO 69.27
- Support Level
- PRME $1.56
- GLO $5.31
- Resistance Level
- PRME $2.78
- GLO $5.46
- Average True Range (ATR)
- PRME 0.26
- GLO 0.05
- MACD
- PRME 0.08
- GLO 0.01
- Stochastic Oscillator
- PRME 76.81
- GLO 92.31
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
About GLO Clough Global Opportunities Fund
Clough Global Opportunities Fund is a closed-end management investment company based in the United States. Its investment objective is to provide a high level of total return by investing in equity securities of companies of any market capitalization and equity-related securities, including equity swaps and call options, as well as fixed-income securities, including both corporate and sovereign debt, in both U.S. and non-U.S. markets.